Recce Pharmaceuticals Ltd (RCE) — Capital Reinvestment Ratio

Latest as of June 2026: 0.10x

Recce Pharmaceuticals Ltd (RCE) has a Capital Reinvestment Ratio of 0.10x as of June 2026, meaning it reinvests 0% of its operating cash flow (AU$341.10K) in capital expenditures (AU$34.98K). Check Recce Pharmaceuticals Ltd (RCE) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

AU$341.10K
AUD

Capital Expenditures

AU$34.98K
AUD

Data as of

Jun 2026
Most recent filing

Recce Pharmaceuticals Ltd Capital Reinvestment Ratio (2014–2014)

This chart tracks Recce Pharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see RCE cash generation efficiency.

Annual Capital Reinvestment Ratio for Recce Pharmaceuticals Ltd (2014–2014)

Year-by-year Capital Reinvestment Ratio for Recce Pharmaceuticals Ltd from 2014 to 2014. See free cash flow generation of Recce Pharmaceuticals Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2014 3.08x AU$11.43K AU$35.25K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow